Treeline Biosciences is a developer of a drug discovery platform for precision medicines for cancer and other serious diseases.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/26/2022 | Series A-1 | $261.27MM | $xx.xx | $111.77B | Access Industries, Arch Venture Partners, Orbimed, Rock Springs Capital | |
Price per Share
$xx.xx
Shares Outstanding
30,343,487
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Access Industries, Arch Venture Partners, Orbimed, Rock Springs Capital
|
||||||
04/09/2021 | Series A | $211.67MM | $xx.xx | $60.48B | Access Industries, Ajax Health/Zeux, Arch Venture Partners, Casdin Capital, Gv, Orbimed | |
Price per Share
$xx.xx
Shares Outstanding
27,041,784
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Access Industries, Ajax Health/Zeux, Arch Venture Partners, Casdin Capital, Gv, Orbimed
|